INTERNATIONAL PATENT: PROLONG PHARMACEUTICALS LLC FILES APPLICATION FOR "IMPROVED DOSING REGIMEN OF PEGYLATED HEMOGLOBIN"

GENEVA, Oct. 28 -- PROLONG PHARMACEUTICALS LLC (300 CORPORATE COURT, SUITE BSOUTH PLAINFIELD, New Jersey 07080) filed a patent application (PCT/US2025/025245) for "IMPROVED DOSING REGIMEN OF PEGYLATED HEMOGLOBIN" on Apr 17, 2025. With publication no. WO/2025/222053, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PANDYA, Shaunak G. (8251 LAFAYETTE LNPISCATAWAY, New Jersey 08854), JUBIN, Ronald (25 BIRCHWOOD LANEWATCHUNG, New Jersey 07069)

Abstract: The present invention discloses an improved infusion process by infusing ...